+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GenePOC Inc - Product Pipeline Analysis, 2019 Update

  • ID: 4050677
  • Company Profile
  • 42 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Amico Corp
  • Rna Diagnostics Inc
  • Xagenic Inc
  • MORE
Summary

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a novel centripetal technology platform. GenePOC also provides automated point-of-care molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The company’s POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, and others. GenePOC is headquartered in Quebec City, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company GenePOC Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amico Corp
  • Rna Diagnostics Inc
  • Xagenic Inc
  • MORE
GenePOC Inc Company Overview
GenePOC Inc Company Snapshot
GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview
GenePOC Inc – Pipeline Analysis Overview
GenePOC Inc - Key Facts
GenePOC Inc - Major Products and Services
GenePOC Inc Pipeline Products by Development Stage
GenePOC Inc Ongoing Clinical Trials by Trial Status
GenePOC Inc Pipeline Products Overview
GenePOC GBS DS Assay
GenePOC GBS DS Assay Product Overview
GenePOC GBS DS Assay Clinical Trial
revogene - Bacillus atrophaeus subsp. globigii Assay
revogene - Bacillus atrophaeus subsp. globigii Assay Product Overview
revogene - Bacillus subtilis Assay
revogene - Bacillus subtilis Assay Product Overview
revogene - Campylobacter jejuni Assay
revogene - Campylobacter jejuni Assay Product Overview
revogene - Candida albicans Assay
revogene - Candida albicans Assay Product Overview
revogene - Clostridium difficile Assay
revogene - Clostridium difficile Assay Product Overview
revogene - Enterococcus faecalis Assay
revogene - Enterococcus faecalis Assay Product Overview
revogene - Escherichia coli Assay
revogene - Escherichia coli Assay Product Overview
revogene - Influenza A Assay
revogene - Influenza A Assay Product Overview
revogene - Respiratory Tract Infections Assay
revogene - Respiratory Tract Infections Assay Product Overview
revogene - Salmonella enterica Assay
revogene - Salmonella enterica Assay Product Overview
revogene - Sexually Transmitted Infections Assay
revogene - Sexually Transmitted Infections Assay Product Overview
revogene - Staphylococcus Assay
revogene - Staphylococcus Assay Product Overview
Triplex Molecular Diagnostic Assay
Triplex Molecular Diagnostic Assay Product Overview
GenePOC Inc - Key Competitors
GenePOC Inc - Key Employees
GenePOC Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Recent Developments
GenePOC Inc, Recent Developments
May 16, 2019: GenePOC Obtains FDA Clearance for its GenePOC Carba Test in the US
Apr 11, 2019: GenePOC obtains CE marked for its GenePOC Carba Test
Mar 21, 2019: GenePOC obtains FDA clearance for its GenePOC Strep A Test in the US
Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC
Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC
Feb 19, 2018: GenePOC Launches Its revogene Instrument and GBS LB Test in Canada
Nov 28, 2017: GenePOC Launches Its GenePOC CDiff Test In The United States
Oct 12, 2017: GenePOC Launches its new GenePOC GBS DS Test
Sep 27, 2017: Genepoc to Attend EMMD in Noortwijk, the Netherlands, From October 11th to 13th
Jun 01, 2017: GenePOC announces FDA clearance for GBS LB test

Appendix
Methodology
Contact Us
Disclaimer

List of Tables
GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview
GenePOC Inc Pipeline Products by Equipment Type
GenePOC Inc Pipeline Products by Indication
GenePOC Inc Ongoing Clinical Trials by Trial Status
GenePOC Inc, Key Facts
GenePOC Inc, Major Products and Services
GenePOC Inc Number of Pipeline Products by Development Stage
GenePOC Inc Pipeline Products Summary by Development Stage
GenePOC Inc Ongoing Clinical Trials by Trial Status
GenePOC Inc Ongoing Clinical Trials Summary
GenePOC GBS DS Assay - Product Status
GenePOC GBS DS Assay - Product Description
GenePOC GBS DS Assay - Prospective Study for Clinical Validation of the Molecular-based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes of Gram-negative Bacteria (blaIMP, blaKPC, blaNDM, blaOXA-48-like and blaVIM) in Rectal Swab Samples From Patients Suspected of Being Colonized. The Targeted Organisms are Enterobacteriaceae, Acinetobacter Baumannii, and Pseudomonas Aeruginosa
revogene - Bacillus atrophaeus subsp. globigii Assay - Product Status
revogene - Bacillus atrophaeus subsp. globigii Assay - Product Description
revogene - Bacillus subtilis Assay - Product Status
revogene - Bacillus subtilis Assay - Product Description
revogene - Campylobacter jejuni Assay - Product Status
revogene - Campylobacter jejuni Assay - Product Description
revogene - Candida albicans Assay - Product Status
revogene - Candida albicans Assay - Product Description
revogene - Clostridium difficile Assay - Product Status
revogene - Clostridium difficile Assay - Product Description
revogene - Enterococcus faecalis Assay - Product Status
revogene - Enterococcus faecalis Assay - Product Description
revogene - Escherichia coli Assay - Product Status
revogene - Escherichia coli Assay - Product Description
revogene - Influenza A Assay - Product Status
revogene - Influenza A Assay - Product Description
revogene - Respiratory Tract Infections Assay - Product Status
revogene - Respiratory Tract Infections Assay - Product Description
revogene - Salmonella enterica Assay - Product Status
revogene - Salmonella enterica Assay - Product Description
revogene - Sexually Transmitted Infections Assay - Product Status
revogene - Sexually Transmitted Infections Assay - Product Description
revogene - Staphylococcus Assay - Product Status
revogene - Staphylococcus Assay - Product Description
Triplex Molecular Diagnostic Assay - Product Status
Triplex Molecular Diagnostic Assay - Product Description
GenePOC Inc, Key Employees
GenePOC Inc, Other Locations
Glossary

List of Figures
GenePOC Inc Pipeline Products by Equipment Type
GenePOC Inc Pipeline Products by Development Stage
GenePOC Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Rna Diagnostics Inc
  • Amico Corp
  • Xagenic Inc
  • Diagnostics Biochem Canada Inc
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4050677
Adroll
adroll